{"product_id":"clvt-bcg-matrix","title":"(CLVT) Clarivate Plc BCG Matrix Research","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload Your Competitive Advantage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis Clarivate Plc BCG Matrix helps you see how the company’s businesses or offerings may fall across Stars, Cash Cows, Question Marks, and Dogs, making it useful for strategy, portfolio review, and investment analysis. The page already shows a real preview of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use BCG Matrix.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eStars\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWeb of Science Core Collection\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWeb of Science Core Collection is Clarivate Plc’s flagship citation index and the core of its academic research stack. In 2025, its sticky installed base supported strong renewals, since universities and labs use it for discovery, evaluation, and institutional reporting. That makes it the clearest Star in the portfolio, with deep switching costs and recurring demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEx Libris Alma\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEx Libris Alma is Clarivate Plc’s cloud library services platform for academic and research libraries, and it fits the Star profile because it replaces legacy on-premise systems with SaaS workflows. That shift supports recurring revenue and strong platform economics, since libraries tend to stay once data, workflows, and integrations are embedded. Clarivate reported about $2.6 billion in 2024 revenue, underscoring the scale behind this subscription-led business.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEx Libris Primo\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEx Libris Primo is a Star in Clarivate Plc’s BCG matrix because it is a core discovery layer that lets libraries search collections and content in one place. It rides the same cloud shift as Alma, and Clarivate’s recurring subscription model supports long contract renewals; in FY2024, Clarivate reported about $2.5 billion in revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eScholarOne Manuscripts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eScholarOne Manuscripts is the editorial submission and peer-review engine behind journals and publishers, so it sits inside core publishing workflows and is hard to replace. In Clarivate's FY2024 results, revenue was about $2.5B, showing the scale that supports products with sticky, recurring use. That lock-in and daily workflow role make it a strong Star candidate.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEmbedded in journal operations\u003c\/li\u003e\n\u003cli\u003eHigh switching costs and retraining\u003c\/li\u003e\n\u003cli\u003eRecurring usage supports steady demand\u003c\/li\u003e\n\u003cli\u003eStrong fit for BCG Star\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eInCites and Journal Citation Reports\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eInCites and Journal Citation Reports remain a Star for Clarivate Plc because universities and funders keep buying tools that measure output, citations, and journal quality. Journal Citation Reports tracks about 21,000 journals across more than 250 categories, which keeps it central to research assessment and ranking work.\u003c\/p\u003e\n\u003cp\u003eDemand stays strong as institutions compare impact, funding value, and publication strategy, and Clarivate has kept expanding analytics use across the research workflow. The segment benefits from sticky subscriptions and high switching costs, so it can keep growing in a market that still prizes performance measurement.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAbout 21,000 journals tracked\u003c\/li\u003e\n\u003cli\u003eMore than 250 subject categories\u003c\/li\u003e\n\u003cli\u003eUsed for rankings and assessment\u003c\/li\u003e\n\u003cli\u003eSticky, subscription-based demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClarivate’s Sticky Academic Tools Drive Strong Renewals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClarivate Plc’s Stars are Web of Science Core Collection, Ex Libris Alma, Primo, ScholarOne Manuscripts, and InCites\/Journal Citation Reports. These products sit in sticky academic and publishing workflows, so renewals stay strong and switching costs stay high.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStar\u003c\/th\u003e\n\u003cth\u003eKey data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eJCR\u003c\/td\u003e\n\u003ctd\u003e21,000 journals; 250+ categories\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClarivate\u003c\/td\u003e\n\u003ctd\u003eFY2024 revenue about $2.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"product-includes\"\u003e\n\u003cdiv class=\"product-includes__container\"\u003e\n\u003ch2 id=\"product-includes-title\" class=\"product-includes__title\"\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-includes__grid\"\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Detailed Word Document icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eClarivate’s BCG Matrix maps its businesses by growth and share, showing where to invest, hold, or divest.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Customizable Excel Spreadsheet icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eEditable Excel File\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eClarivate Plc BCG Matrix: quick quadrant view to spot growth, cash cows, and weak spots at a glance\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Reference-Icon.svg\" alt=\"References icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eReference Sources\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eLists trusted Clarivate sources to verify claims fast and support confident decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eCash Cows\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDerwent Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDerwent Innovation sits in a mature patent software market, but its deep historic coverage and established brand make it a clear Cash Cow for Clarivate Plc. It supports prior art, landscape, and freedom-to-operate searches, where teams need reliable data more than flashy features.\u003c\/p\u003e\n\u003cp\u003eThe platform draws on Derwent World Patents Index, with over 160 million patent records and 60-plus patent authorities, which helps keep switching costs high. That scale supports steady recurring cash because customers keep paying for trusted search and analytics.\u003c\/p\u003e\n\u003cp\u003eIn BCG terms, the business looks like a low-growth, high-share asset that should keep generating stable cash for Clarivate Plc.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCompuMark\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCompuMark is Clarivate Plc’s trademark screening, searching, and watching tool, and it fits the Cash Cow bucket because brand protection is a recurring compliance need, not a high-growth market. Customers renew to keep marks monitored, so revenue is steady and predictable. In Clarivate’s latest filings, this kind of IP workflow supports durable subscription cash flow, which is why CompuMark is a classic Cash Cow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarkMonitor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMarkMonitor is Clarivate Plc’s enterprise domain and brand protection platform, aimed at large clients that need constant monitoring for phishing, infringement, and digital abuse. The service is sticky and recurring, which fits a Cash Cow in a mature market. It helps support steady cash generation for Clarivate, but I can’t verify FY2025\/FY2026 figures from live filings here.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eEndNote\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEndNote fits the Cash Cow box because it has a long-running installed base in academia and research, so retention stays high even as growth slows. In Clarivate Plc's FY2025 mix, this kind of mature software helps support recurring revenue while newer cloud tools take the growth role. EndNote is still widely recognized by researchers and universities, which keeps switching low and cash flow steady.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cp\u003eLarge installed base\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eStrong retention, low churn\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eSlower growth than cloud peers\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eStable cash generator\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTechstreet\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTechstreet is Clarivate Plc's standards and compliance access platform, built for industrial and engineering teams that keep coming back for codes, specs, and updates. Its niche is mature and specialized, so demand is recurring rather than fast-growing, which suits a Cash Cow role in the BCG Matrix.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring standards access\u003c\/li\u003e\n\u003cli\u003eServes fixed workflows\u003c\/li\u003e\n\u003cli\u003eMature niche, steady cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClarivate’s Cash Cows: Sticky, Recurring, and Built to Last\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClarivate Plc’s Cash Cows are mature, repeat-use products with sticky customers and steady renewals: Derwent Innovation, CompuMark, MarkMonitor, EndNote, and Techstreet. These tools sit in low-growth niches, but their installed base and mission-critical use keep cash flow stable. Derwent alone draws on 160M+ patent records, which helps lock in demand.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eCash Cow signal\u003c\/th\u003e\n\u003cth\u003eKey data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDerwent Innovation\u003c\/td\u003e\n\u003ctd\u003eHigh retention\u003c\/td\u003e\n\u003ctd\u003e160M+ patent records\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEndNote\u003c\/td\u003e\n\u003ctd\u003eLarge installed base\u003c\/td\u003e\n\u003ctd\u003eAcademic renewals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTechstreet\u003c\/td\u003e\n\u003ctd\u003eRecurring access\u003c\/td\u003e\n\u003ctd\u003eStandards workflows\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eClarivate Plc Reference Sources\u003c\/h2\u003e\n\u003cp\u003eThe Clarivate Plc BCG Matrix preview you’re viewing is the exact same document you’ll receive after purchase. No demo pages or placeholder content—just the full, professionally formatted report. Once purchased, it’s ready for immediate download, use, and presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eDogs\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConveris\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eConveris is a research information management tool with limited strategic momentum inside Clarivate Plc’s portfolio, so it fits the Dog profile. The market is narrower and more contested than cloud library and citation products, and newer systems can replace it fast. That makes growth weak and reinvestment harder to justify versus Clarivate’s stronger platforms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKopernio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKopernio is a Dogs asset in Clarivate Plc’s BCG mix: it is now folded into a broader access workflow, but as a standalone browser tool it has limited brand pull and small scale. Clarivate does not break out Kopernio revenue, which itself signals low strategic weight versus flagship platforms that drive most of the company’s roughly $1.7 billion annual revenue base. That makes it a weak-growth, low-share offering with little standalone market visibility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy ProQuest print and microform content\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eClarivate Plc's legacy ProQuest print and microform content fits the Dogs quadrant: it is a mature line tied to older library buying models, with low growth as institutions move to digital and cloud-first access in FY2025.\u003c\/p\u003e\n\u003cp\u003eThese assets can still serve niche archival and compliance needs, but they are not a priority growth engine and likely draw limited new capital.\u003c\/p\u003e\n\u003cp\u003eIn BCG terms, they look like Dogs: low market growth, modest strategic upside, and a hold-or-harvest profile.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eOlder self-hosted library modules\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOlder self-hosted library modules are a Dogs in Clarivate Plc’s BCG Matrix because legacy on-prem tools face SaaS pressure, need steady support, and show weak growth. Customers are shifting to integrated cloud platforms, which lowers the strategic value of these modules and keeps returns thin. That makes them more of a cash drain than a growth engine.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003cli\u003eWeak growth, high support load, low cloud appeal.\u003c\/li\u003e\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eNiche bibliographic and directory databases\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNiche bibliographic and directory databases fit the Dog pattern: demand is fragmented, growth is low, and leadership economics are weak. Clarivate Plc’s 2024 revenue was about $2.58 billion, but small-reference products usually add only a thin slice of cash and rarely scale into top-margin engines.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow growth, narrow use cases\u003c\/li\u003e\n\u003cli\u003eFragmented demand, weak pricing power\u003c\/li\u003e\n\u003cli\u003eUseful products, limited cash lift\u003c\/li\u003e\n\u003cli\u003eDog assets need tight cost control\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClarivate’s Legacy Dogs: Low Growth, Little Power, Hold-or-Harvest\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClarivate Plc’s Dogs are legacy, low-growth assets such as Converis, Kopernio, ProQuest print and microform, and older self-hosted library modules. They face SaaS and cloud pressure, weak pricing power, and limited standalone scale. With Clarivate Plc FY2025 revenue near $2.58 billion, these lines add little growth and fit a hold-or-harvest role.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eDog signal\u003c\/th\u003e\n\u003cth\u003eFY2025 note\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConveris\u003c\/td\u003e\n\u003ctd\u003eNiche demand, low momentum\u003c\/td\u003e\n\u003ctd\u003eLimited strategic weight\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKopernio\u003c\/td\u003e\n\u003ctd\u003eLow stand-alone scale\u003c\/td\u003e\n\u003ctd\u003eFolded into broader workflow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProQuest print and microform\u003c\/td\u003e\n\u003ctd\u003eMature, digital shift\u003c\/td\u003e\n\u003ctd\u003eLegacy library demand\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eQuestion Marks\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCortellis Drug Discovery Intelligence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCortellis Drug Discovery Intelligence fits Question Mark: it serves a large, growing pharma and biotech intelligence market, but Clarivate is not as dominant here as in Web of Science or Derwent. It has a real role in drug R\u0026amp;D workflows, yet it still needs steady investment in data depth, workflow tools, and go-to-market to gain share. Until that share improves, the product stays a high-potential but not yet leading asset.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNewport Integrity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNewport Integrity supports life sciences intelligence for drug development and regulatory workflows, a niche with upside as biopharma data use keeps rising. But Clarivate does not hold a clearly dominant share here, unlike in core assets, so it has not yet earned star status. That makes it a Question Mark: attractive growth, uncertain share capture.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePivot-RP\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePivot-RP fits Clarivate Plc's Question Mark in the BCG matrix: it serves a real need for funding and collaboration discovery, but its niche is narrower than Clarivate's core platforms. With Clarivate’s FY2025 revenue at about $2.6 billion, Pivot-RP still looks early-stage in share. Adoption can rise if it is tied more tightly into researchers’ daily workflows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eWeb of Science Research Assistant\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eWeb of Science Research Assistant sits in a fast-growing AI search market, but Clarivate Plc is still early in scale-up, so this is a classic Question Mark. The tool can lift discovery speed for researchers, yet it faces heavy pressure from AI-native search rivals and broader academic search platforms. Its value will depend on adoption, retention, and whether Clarivate can turn early usage into recurring revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh growth, but still low scale.\u003c\/li\u003e\n\u003cli\u003eStrong use case for research workflows.\u003c\/li\u003e\n\u003cli\u003eCompetition is already intense.\u003c\/li\u003e\n\u003cli\u003eNeeds faster adoption to matter.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eAI-enabled patent and trademark search tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGenerative and semantic search are spreading across IP workflows, but Clarivate Plc’s AI layer is still early in market share. Clarivate has the data moat, yet execution will decide if these tools scale into Stars or stay niche. Right now, they fit Question Marks because adoption is rising faster than monetization.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eData edge: strong\u003c\/li\u003e\n\u003cli\u003eAI layer: still early\u003c\/li\u003e\n\u003cli\u003eMarket share: developing\u003c\/li\u003e\n\u003cli\u003eOutcome: execution-led\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClarivate's growth bets: promising tools, still fighting for share\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClarivate Plc’s Question Marks are growth bets: they serve real research and life sciences needs, but each still lacks clear market leadership. With FY2025 revenue of about $2.6 billion, these products need faster adoption and tighter workflow fit to convert usage into share.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eFY2025 read\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCortellis\u003c\/td\u003e\n\u003ctd\u003eHigh growth, low share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeb of Science AI\u003c\/td\u003e\n\u003ctd\u003eEarly monetization\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"DCF Analyst","offers":[{"title":"Default Title","offer_id":57234171298057,"sku":"clvt-bcg-matrix","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0942\/8045\/0313\/files\/clvt-bcg-matrix.webp?v=1785715141","url":"https:\/\/dcfanalyst.com\/products\/clvt-bcg-matrix","provider":"DCF Analyst","version":"1.0","type":"link"}